Mirae Asset Global ETFs Holdings
AMLX icon

Mirae Asset Global ETFs Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
42,351
-202
-0.5% -$3.12K ﹤0.01% 1776
2026
Q1 		$591K Buy
42,553
+1,387
+3% +$19.5K ﹤0.01% 1800
2025
Q4 		$497K Buy
41,166
+9,167
+29% +$125K ﹤0.01% 1900
2025
Q3 		$435K Sell
31,999
-5,988
-16% -$56.4K ﹤0.01% 1929
2025
Q2 		$243K Buy
+37,987
New +$185K ﹤0.01% 2179
2024
Q3 		– Sell
-26,032
Closed -$49.5K – 3074
2024
Q2 		$49.5K Buy
+26,032
New +$50.4K ﹤0.01% 2791

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's AMLX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Amylyx Pharmaceuticals (AMLX) stake by 0.47% in Q2 2026, selling an estimated $3.12K and leaving 42,351 shares worth $761K. The position accounts for ﹤0.01% of the portfolio, ranked #1776.

Mirae Asset Global ETFs Holdings first reported a position in AMLX in Q2 2024 and has held it in 6 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 42,351 shares of Amylyx Pharmaceuticals worth $761K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 202 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $3.12K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1776 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Amylyx Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.